Belén Garijo

Chief Executive Officer · Sanofi

Pharmaceuticals

Belén Garijo is chief executive officer of Sanofi, having previously led Merck Group and held clinical, commercial and operating roles across the pharmaceutical industry.

Last reviewed: Nov 15, 2026

Belén Garijo

Executive Summary

Belén Garijo is chief executive officer of Sanofi, having previously led Merck Group and held clinical, commercial and operating roles across the pharmaceutical industry.

Career Highlights

  • Began her pharmaceutical career at Abbott after clinical practice in Madrid.
  • Led Merck Group from 2021 to 2026.
  • Became Sanofi CEO on May 1, 2026.

Professional Journey

Garijo began in clinical practice at Hospital La Paz in Madrid, specializing in clinical pharmacology. She subsequently moved into the pharmaceutical industry at Abbott Laboratories, serving as medical director in Spain from 1989 to 1994 and international medical director in Illinois from 1994 to 1996.

At Rhône-Poulenc, she directed oncology in Spain from 1996 to 1999. Her Aventis responsibilities then broadened from oncology, central nervous system and insulin products in Spain to global oncology leadership in New Jersey, followed by general management of its Spanish business.

After the creation of Sanofi Aventis, Garijo led its Spanish operations from 2004 to 2006 and commercial operations for Europe and Canada from 2006 to 2011. Her work at Sanofi included leading the integration of Genzyme following its acquisition.

She joined Merck in 2011 as chief operating officer of Merck Serono. She became its chair and CEO in 2013, joined Merck’s executive board as healthcare CEO in 2015 and became group deputy CEO in 2020. From 2021 to 2026 she chaired the executive board and served as CEO of Merck Group.

Garijo returned to Sanofi as chief executive on May 1, 2026. Her leadership career has encompassed medical affairs, therapeutic-area management, national and regional commercial operations, acquisition integration and responsibility for a diversified science and technology group.

Education

Garijo earned her medical degree at Universidad de Alcalá de Henares and specialized in clinical pharmacology at Hospital La Paz. BBVA’s published curriculum vitae also records a master’s in business and management from Ashridge Management School.